StockData
Labcorp Holdings Inc. logo

Labcorp Holdings Inc. (LH) stock

LHNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3018% above fair value
$372.46+1.98 (+0.53%)

Close on Nov 16, 2026Market cap $30.24BP/E 30.6Yield 0.77%

Labcorp ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Labcorp's ebitda for the twelve months ending Sep 30, 2026 was $2.21B, up 9.8% year over year. For fiscal 2025 it was $2.07B, up 19.4% from the year before. Over ten years it grew 3.6% a year on average. The highest annual figure on record is $3.63B in fiscal 2021.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.07B+19.4%
FY2024Dec 31, 2024$1.73B+32.8%
FY2023Dec 31, 2023$1.30B-34.0%
FY2022Dec 31, 2022$1.97B-45.6%
FY2021Dec 31, 2021$3.63B+18.1%
FY2020Dec 31, 2020$3.07B+61.0%
FY2019Dec 31, 2019$1.91B+1.6%
FY2018Dec 31, 2018$1.88B+2.1%
FY2017Dec 31, 2017$1.84B+3.9%
FY2016Dec 31, 2016$1.77B+21.7%
FY2015Dec 31, 2015$1.45B+25.8%
FY2014Dec 31, 2014$1.16B-5.3%
FY2013Dec 31, 2013$1.22B-2.6%
FY2012Dec 31, 2012$1.25B+6.2%
FY2011Dec 31, 2011$1.18B-0.2%
FY2010Dec 31, 2010$1.18B+4.5%
FY2009Dec 31, 2009$1.13B+10.6%
FY2008Dec 31, 2008$1.02B+8.8%
FY2007Dec 31, 2007$939.80M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$585.10M+3.1%
Q2 FY2026Jun 30, 2026$630.60M+11.7%
Q1 FY2026Mar 31, 2026$554.10M+12.4%
Q4 FY2025Dec 31, 2025$440.60M+13.8%
Q3 FY2025Sep 30, 2025$567.60M+36.6%
Q2 FY2025Jun 30, 2025$564.80M+25.0%
Q1 FY2025Mar 31, 2025$492.80M+3.6%
Q4 FY2024Dec 31, 2024$387.10M+1540.3%
Q3 FY2024Sep 30, 2024$415.60M+4.4%
Q2 FY2024Jun 30, 2024$451.70M+10.4%
Q1 FY2024Mar 31, 2024$475.80M+0.8%
Q4 FY2023Dec 31, 2023$23.60M-85.1%
Q3 FY2023Sep 30, 2023$398.20M-21.6%
Q2 FY2023Jun 30, 2023$409.20M-24.2%
Q1 FY2023Mar 31, 2023$471.90M-44.4%
Q4 FY2022Dec 31, 2022$158.90M-70.6%
Q3 FY2022Sep 30, 2022$508.10M-46.7%
Q2 FY2022Jun 30, 2022$540.00M-39.4%
Q1 FY2022Mar 31, 2022$849.40M-31.6%
Q4 FY2021Dec 31, 2021$539.60M-63.5%
Q3 FY2021Sep 30, 2021$953.00M-20.5%
Q2 FY2021Jun 30, 2021$891.20M+101.8%
Q1 FY2021Mar 31, 2021$1.24B–
Q4 FY2020Dec 31, 2020$1.48B+200.1%
Q3 FY2020Sep 30, 2020$1.20B+147.7%
Q2 FY2020Jun 30, 2020$441.60M-7.5%
Q1 FY2020Mar 31, 2020-$48.00M-110.6%
Q4 FY2019Dec 31, 2019$492.20M+10.5%
Q3 FY2019Sep 30, 2019$484.20M+1.6%
Q2 FY2019Jun 30, 2019$477.30M-6.0%
Q1 FY2019Mar 31, 2019$453.70M+1.2%
Q4 FY2018Dec 31, 2018$445.40M-6.3%
Q3 FY2018Sep 30, 2018$476.50M+3.6%
Q2 FY2018Jun 30, 2018$507.70M+11.1%
Q1 FY2018Mar 31, 2018$448.20M+0.4%
Q4 FY2017Dec 31, 2017$475.60M+15.5%
Q3 FY2017Sep 30, 2017$459.80M–
Q2 FY2017Jun 30, 2017$456.80M–
Q1 FY2017Mar 31, 2017$446.20M–
Q4 FY2016Dec 31, 2016$411.90M–

More Labcorp figures

See a number that looks wrong?